Vol. 57 No. s4 (2005)

7 articles Published 30 December 2005

Original Articles

7 articles Browse this section

Are there differences among anti-TNFa biological drugs?

G. Valesini

Pages 1-2

DOI https://doi.org/10.4081/reumatismo.2005.4s.1
- 971 abstract views
- 729 PDF
- PDF
Effects of TNF antagonists on immune and neuroendocrine system

G. Valesini, M. Cutolo

Pages 3-7

DOI https://doi.org/10.4081/reumatismo.2005.4s.3
- 1,669 abstract views
- 930 PDF
- PDF
Differences in pharmacology of tumor necrosis factor (TNF) antagonists

U. Fiocco, S. Bombardieri

Pages 8-16

DOI https://doi.org/10.4081/reumatismo.2005.4s.8
- 1,468 abstract views
- 1,917 PDF
- PDF
Biologic therapy with anti-TNFa in rheumathoid atrhritis

G. Ferraccioli

Pages 17-21

DOI https://doi.org/10.4081/reumatismo.2005.4s.17
- 948 abstract views
- 790 PDF
- PDF
Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

G. Lapadula

Pages 22-29

DOI https://doi.org/10.4081/reumatismo.2005.4s.22
- 1,031 abstract views
- 1,239 PDF
- PDF
Approved indications and other possible utilizations of anti-TNFa biologic drugs

W. Grassi, C. Montecucco

Pages 30-33

DOI https://doi.org/10.4081/reumatismo.2005.4s.30
- 1,458 abstract views
- 975 PDF
- PDF
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

Pages 34-39

DOI https://doi.org/10.4081/reumatismo.2005.4s.34
- 1,491 abstract views
- 1,641 PDF
- PDF